Status:
COMPLETED
Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
Lead Sponsor:
Central Institute of Mental Health, Mannheim
Conditions:
Healthy Humans
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
Attentional blink refers to a phenomenon where the detection of the second of two target stimuli that are presented in Short succession within a stream of stimuli is impaired. This is explained by an ...
Eligibility Criteria
Inclusion
- male
- age between 18 and 65 years
- right-handed
Exclusion
- consumption of cannabis more than 5 times
- substance abuse (apart from nicotine)
- psychiatric disorders
- epilepsy
- chronic diseases (e.g. diabetes)
Key Trial Info
Start Date :
February 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02291536
Start Date
February 1 2014
End Date
December 1 2014
Last Update
January 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Institute of Mental Health
Mannheim, Germany, 68159